This book aims to provide an up-to-date review of the literature in each of the major areas relating to the management of older urological cancer patients, and makes recommendations for best practice and future research. The authors come from a broad geographic spread including the UK, mainland Europe and North America to ensure a worldwide relevance.

Managing urologic cancer by preserving, as opposed to removing, affected tissue, is rapidly becoming the favoured choice for urologists and oncologists. Discover all available options and how to achieve the best possible patient management with this expert guide to the area. The editor, Mark Schoenberg, is an internationally-renown expert in this exciting new area and has recruited an outstanding team featuring some of the leading urologists/oncologists in North America and Europe to assist him.

The book provides comprehensive review of common uro-oncology cases mainly focusing on its management aspect. It includes diagnosis and clinical staging, surgical management, pathological staging, adjuvant treatment and follow up. It provides current evidence-based approaches for the management of common urological malignancies. All the chapters are written uniformly in a simple yet informative manner by experts in their respective fields. It contains well-prepared illustrations, relevant clinical images and flowcharts. The book is helpful for practicing urologists, uro-oncologists, oncologists as well as urology trainees, uro-oncology fellows in providing a holistic approach to cancer patients. It helps them to develop critical thinking and encourage discussion toward improving the overall care of the patients.

This simple, brief and succinct handbook covers all the salient features of management of genito-urinary (GU) cancers and contains all the important principles of GU cancer management. A key feature of this book is an easy-to-look-up reference guide to step-by-step management strategies and drug dosages designed mainly for the trainee doctor in an emergency situation. Additionally, the book answers many questions patients ask for which there are no answers readily available in standard textbooks, e.g. dietary requirements during chemotherapy and radiotherapy. Invaluable to residents, specialists, nurse practitioners, and medical secretaries in Urology, Radiotherapy, Oncology and Palliative Medicine as related to urological cancers.

Although very common, urological cancers rarely receive headline acknowledgement. In the developed world, prostate cancer continues to increase in both incidence and prevalence and is now the second leading cause of cancer death in the UK. In addition, testicular cancers are also increasing and bladder tumours are becoming more common in women. Advances in cancer treatment, in some cases initiated in the field of urology, have dramatically changed the way some cancers are handled. Chemotherapy has transformed survival in testicular cancer and cytokines are active in renal cell cancer, while intravesical BCG treatment plays a significant role in the management of bladder cancer. Aimed at all health professionals working in urological oncology, Urological Cancer provides comprehensive yet concise diagnostic, radiotherapeutic and surgical overviews of urological tumours, malignant and benign.

Cancer forms a large part of urological practice. Prostate cancer is the most significant and is the second most common cause of male cancer deaths with some 300,000 cases in the USA annually. Cancer of the bladder is also common. While treatment has been primarily surgical, recent years have seen an explosion of new drug therapies for urological cancers. All urologists, whether in training or in practice, need an up-to-date survey of the literature and key findings in this important and controversial field. This book takes each organ in turn (prostate, kidney, bladder, testis and penis) and tackles the controversies head-on by inviting chapters on various (often rival) treatments for each disease. Each section is then concluded by a commentary from the editor which draws together the various strands, outlines the principal areas of consensus and disagreement. Jonathan Waxman is an oncologist who specialises in urological tumours and has developed new treatments for prostate, bladder and kidney cancer and for terminal care, which are now part of standard practice. He founded the Prostate Cancer Charity and helped establish an all-party parliamentary group to improve cancer treatment and research throughout the UK.

Encompasses all areas of urological cancers Combines clinical and molecular advances in one volume Only available book specific to the whole of urological malignancies Appeals equally to urologists and oncologists The well-known author has published over 250 research papers and eleven books on cancer and is also the founder of the "Prostate Cancer Charity"